Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,667,871
-$37,738,686 QoQ
Shares Held
8,081,089
0.0% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
21.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Omega Fund Management, LLC holds $129,582,182 across 8 Biotechnology names. NUVB ranks #2 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
|
2,392,150 | $47,579,863 | |
| 2 | NUVB |
Nuvation Bio Inc.
This page
|
8,081,089 | $34,667,871 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
3,289,661 | $29,442,465 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $5,967,991 | |
| 5 | ALMS |
Alumis Inc.
|
241,255 | $5,314,847 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
843,750 | $2,430,000 | |
| 7 | IMA |
ImageneBio, Inc.
|
455,361 | $2,276,805 | |
| 8 | REPL |
Replimune Group, Inc.
|
248,672 | $1,902,340 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,667,871 | 8,081,089 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $72,406,557 | 8,081,089 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,675,029 | 8,831,089 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,533,319 | 11,042,728 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,007,318 | 13,072,340 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,772,424 | 13,072,340 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,935,658 | 13,072,340 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $38,765,581 | 13,275,884 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,223,317 | 14,072,340 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,759,233 | 15,072,340 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,196,935 | 15,072,340 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,130,212 | 15,072,340 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,020,084 | 15,072,340 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,938,892 | 15,072,340 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $33,762,041 | 15,072,340 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,401,381 | 15,247,340 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $120,755,608 | 22,957,340 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $195,137,390 | 22,957,340 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $280,431,017 | 28,212,376 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $262,657,220 | 28,212,376 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $294,819,329 | 28,212,376 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||